CannPal’s privatisation pays off with major US partnership

Almost two years after buying back majority control of CannPal Animal Therapeutics from the recently delisted AusCann, CEO and founder Layton Mills has struck a major partnership agreement that could see the company’s medicinal cannabis products for pets commercialised in the US market.

CannPal…